Inclusion Technologies® Sponsors and Supports CLEAR™
Inclusion Technologies® has recently announced is sponsorship and support of CLEAR™ (Coalition for Lifesaving Epinephrine Access Responsibility), the Coalition for Lifesaving Epinephrine Access Responsibility.
CLEAR™, is a growing coalition of concerned public, non-profits and industry stakeholders who are making their voices heard to ensure that these lifesaving epinephrine auto-injectors (EAI’s) are readily accessible on all domestic commercial aircraft. Recent life-threatening occurrences of multiple passengers on commercial airlines having suffered an allergic attack have elevated the critical, urgent need for the U.S. Congress to begin considering how best to ensure passengers on commercial airplanes have access to lifesaving epinephrine auto-injectors. Currently, these epinephrine auto-injectors are not stocked on, and therefore not readily accessible, to passengers on commercial airlines. According to Robert Houghton, Founder of CLEAR™, “this outdated and ineffective method must be updated so that commercial aircraft is stocked with epinephrine auto-injectors for passengers who suffer life threatening allergic attacks on commercial aircrafts.”
Dennis Reid, Founder and President of Inclusion Technologies said, “Our company focuses on and manufactures products that service the nut-free community, and we were looking for a way to give back to and support this growing community, and to help them protect their loved ones with nut allergies. After Robert and I discussed the CLEAR effort, I knew that we had found a very worth cause to support”.